Neutralization mechanisms of two highly potent antibodies against human enterovirus 71

Despite significant advances in health care, outbreaks of infections by enteroviruses (EVs) continue to plague the Asia-Pacific region every year. Enterovirus 71 (EV71) causes hand-foot-and-mouth disease (HFMD), for which there are currently no therapeutics. Here, we report two new antibodies, A9 an...

Full description

Bibliographic Details
Main Authors: Zhu, L, Xu, K, Wang, N, Cao, L, Wu, J, Gao, Q, Fry, E, Stuart, D, Rao, Z, Wang, J, Wang, X
Format: Journal article
Language:English
Published: American Society for Microbiology 2018
_version_ 1797059533537804288
author Zhu, L
Xu, K
Wang, N
Cao, L
Wu, J
Gao, Q
Fry, E
Stuart, D
Rao, Z
Wang, J
Wang, X
author_facet Zhu, L
Xu, K
Wang, N
Cao, L
Wu, J
Gao, Q
Fry, E
Stuart, D
Rao, Z
Wang, J
Wang, X
author_sort Zhu, L
collection OXFORD
description Despite significant advances in health care, outbreaks of infections by enteroviruses (EVs) continue to plague the Asia-Pacific region every year. Enterovirus 71 (EV71) causes hand-foot-and-mouth disease (HFMD), for which there are currently no therapeutics. Here, we report two new antibodies, A9 and D6, that potently neutralize EV71. A9 exhibited a 50% neutralizing concentration (neut50) value of 0.1 nM against EV71, which was 10-fold lower than that observed for D6. Investigation into the mechanisms of neutralization revealed that binding of A9 to EV71 blocks receptor binding but also destabilizes and damages the virus capsid structure. In contrast, D6 destabilizes the capsid only slightly but interferes more potently with the attachment of the virus to the host cells. Cryo-electron microscopy (cryo-EM) structures of A9 and D6 bound with EV71 shed light on the locations and nature of the epitopes recognized by the two antibodies. Although some regions of the epitopes recognized by the two antibodies overlap, there are differences that give rise to dissimilarities in potency as well as in the mechanisms of neutralization. Interestingly, the overlapping regions of the epitopes encompass the site that the virus uses to bind SCARB2, explaining the reason for the observed blocking of the virus-receptor interaction by the two antibodies. We also identified structural elements that might play roles in modulating the stability of the EV71 particles, including particle integrity. The molecular features of the A9 and D6 epitopes unveiled in this study open up new avenues for rationally designing antiviral drugs.
first_indexed 2024-03-06T20:05:38Z
format Journal article
id oxford-uuid:28cff7fe-47f6-40de-b82b-14bf992c1ebe
institution University of Oxford
language English
last_indexed 2024-03-06T20:05:38Z
publishDate 2018
publisher American Society for Microbiology
record_format dspace
spelling oxford-uuid:28cff7fe-47f6-40de-b82b-14bf992c1ebe2022-03-26T12:15:18ZNeutralization mechanisms of two highly potent antibodies against human enterovirus 71Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:28cff7fe-47f6-40de-b82b-14bf992c1ebeEnglishSymplectic Elements at OxfordAmerican Society for Microbiology2018Zhu, LXu, KWang, NCao, LWu, JGao, QFry, EStuart, DRao, ZWang, JWang, XDespite significant advances in health care, outbreaks of infections by enteroviruses (EVs) continue to plague the Asia-Pacific region every year. Enterovirus 71 (EV71) causes hand-foot-and-mouth disease (HFMD), for which there are currently no therapeutics. Here, we report two new antibodies, A9 and D6, that potently neutralize EV71. A9 exhibited a 50% neutralizing concentration (neut50) value of 0.1 nM against EV71, which was 10-fold lower than that observed for D6. Investigation into the mechanisms of neutralization revealed that binding of A9 to EV71 blocks receptor binding but also destabilizes and damages the virus capsid structure. In contrast, D6 destabilizes the capsid only slightly but interferes more potently with the attachment of the virus to the host cells. Cryo-electron microscopy (cryo-EM) structures of A9 and D6 bound with EV71 shed light on the locations and nature of the epitopes recognized by the two antibodies. Although some regions of the epitopes recognized by the two antibodies overlap, there are differences that give rise to dissimilarities in potency as well as in the mechanisms of neutralization. Interestingly, the overlapping regions of the epitopes encompass the site that the virus uses to bind SCARB2, explaining the reason for the observed blocking of the virus-receptor interaction by the two antibodies. We also identified structural elements that might play roles in modulating the stability of the EV71 particles, including particle integrity. The molecular features of the A9 and D6 epitopes unveiled in this study open up new avenues for rationally designing antiviral drugs.
spellingShingle Zhu, L
Xu, K
Wang, N
Cao, L
Wu, J
Gao, Q
Fry, E
Stuart, D
Rao, Z
Wang, J
Wang, X
Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
title Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
title_full Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
title_fullStr Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
title_full_unstemmed Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
title_short Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
title_sort neutralization mechanisms of two highly potent antibodies against human enterovirus 71
work_keys_str_mv AT zhul neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT xuk neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT wangn neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT caol neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT wuj neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT gaoq neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT frye neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT stuartd neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT raoz neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT wangj neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71
AT wangx neutralizationmechanismsoftwohighlypotentantibodiesagainsthumanenterovirus71